Intuitive Surgical, Inc. (LON:0R29)

Market Cap	150.78B
Revenue (ttm)	7.15B
Net Income (ttm)	2.04B
Shares Out	n/a
EPS (ttm)	5.62
PE Ratio	73.78
Forward PE	59.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,936
Average Volume	2,794
Open	547.38
Previous Close	546.21
Day's Range	539.19 - 561.00
52-Week Range	406.50 - 616.00
Beta	1.69
RSI	75.70
Earnings Date	Jan 21, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 15,638
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R29

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.

Financial numbers in USD